TrialBritish journal of clinical pharmacology2007

Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.

Thorsten Lehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.